Filing Details
- Accession Number:
- 0001209191-21-042424
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-06-22 17:00:50
- Reporting Period:
- 2021-06-21
- Accepted Time:
- 2021-06-22 17:00:50
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1490978 | Schrodinger Inc. | SDGR | Pharmaceutical Preparations (2834) | 954284541 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1798179 | Lorne Robert Abel | C/O Schrodinger, Inc., 120 West 45Th Street, 17Th Floor New York NY 10036 | See Remarks | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-06-21 | 7,814 | $17.00 | 7,814 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-06-21 | 5,574 | $4.34 | 13,388 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2021-06-21 | 2,214 | $2.92 | 15,602 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2021-06-21 | 15,602 | $74.16 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2021-06-21 | 2,214 | $0.00 | 2,214 | $2.92 |
| Common Stock | Stock Option (right to buy) | Disposition | 2021-06-21 | 5,574 | $0.00 | 5,574 | $4.34 |
| Common Stock | Stock Option (right to buy) | Disposition | 2021-06-21 | 7,814 | $0.00 | 7,814 | $17.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2027-06-01 | No | 4 | M | Direct | |
| 11,148 | 2028-11-29 | No | 4 | M | Direct | |
| 125,959 | 2030-02-05 | No | 4 | M | Direct |
Footnotes
- These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 17, 2021.
- The option was granted on June 1, 2017 and is fully vested.
- This option was granted on November 29, 2018. The shares underlying the option vested with respect to 25% of the shares on December 31, 2019 and the remainder are scheduled to vest in equal monthly installments through December 31, 2022.
- This option was granted on February 5, 2020. The shares underlying the option vested with respect to 25% of the shares on February 5, 2021 and the remainder are scheduled to vest in equal monthly installments through February 5, 2024.
Billionaire Hedge Funds
